These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 23312272)

  • 1. Hippocampal dosimetry predicts neurocognitive function impairment after fractionated stereotactic radiotherapy for benign or low-grade adult brain tumors.
    Gondi V; Hermann BP; Mehta MP; Tomé WA
    Int J Radiat Oncol Biol Phys; 2013 Feb; 85(2):348-54. PubMed ID: 23312272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hippocampal dosimetry predicts neurocognitive function impairment after fractionated stereotactic radiotherapy for benign or low-grade adult brain tumors.
    Gondi V; Hermann BP; Mehta MP; Tomé WA
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):e487-93. PubMed ID: 22209148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hippocampal dosimetry correlates with the change in neurocognitive function after hippocampal sparing during whole brain radiotherapy: a prospective study.
    Tsai PF; Yang CC; Chuang CC; Huang TY; Wu YM; Pai PC; Tseng CK; Wu TH; Shen YL; Lin SY
    Radiat Oncol; 2015 Dec; 10():253. PubMed ID: 26654128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hippocampus-sparing radiotherapy using volumetric modulated arc therapy (VMAT) to the primary brain tumor: the result of dosimetric study and neurocognitive function assessment.
    Kim KS; Wee CW; Seok JY; Hong JW; Chung JB; Eom KY; Kim JS; Kim CY; Park YH; Kim YJ; Kim IA
    Radiat Oncol; 2018 Feb; 13(1):29. PubMed ID: 29463267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Radiation-Induced Hippocampal Vascular Injury Surrogate Marker Predicts Late Neurocognitive Dysfunction.
    Farjam R; Pramanik P; Aryal MP; Srinivasan A; Chapman CH; Tsien CI; Lawrence TS; Cao Y
    Int J Radiat Oncol Biol Phys; 2015 Nov; 93(4):908-15. PubMed ID: 26530761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality assurance analysis of hippocampal avoidance in a melanoma whole brain radiotherapy randomized trial shows good compliance.
    Martinage G; Hong AM; Fay M; Thachil T; Roos D; Williams N; Lo S; Fogarty G
    Radiat Oncol; 2018 Jul; 13(1):132. PubMed ID: 30029684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hippocampal radiotherapy dose constraints for predicting long-term neurocognitive outcomes: mature data from a prospective trial in young patients with brain tumors.
    Goda JS; Dutta D; Krishna U; Goswami S; Kothavade V; Kannan S; Maitre M; Bano N; Gupta T; Jalali R
    Neuro Oncol; 2020 Nov; 22(11):1677-1685. PubMed ID: 32227185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between hippocampal dose and memory in survivors of childhood or adolescent low-grade glioma: a 10-year neurocognitive longitudinal study.
    Acharya S; Wu S; Ashford JM; Tinkle CL; Lucas JT; Qaddoumi I; Gajjar A; Krasin MJ; Conklin HM; Merchant TE
    Neuro Oncol; 2019 Sep; 21(9):1175-1183. PubMed ID: 30977510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative Imaging Biomarkers of Damage to Critical Memory Regions Are Associated With Post-Radiation Therapy Memory Performance in Brain Tumor Patients.
    Tringale KR; Nguyen TT; Karunamuni R; Seibert T; Huynh-Le MP; Connor M; Moiseenko V; Gorman MK; Marshall A; Tibbs MD; Farid N; Simpson D; Sanghvi P; McDonald CR; Hattangadi-Gluth JA
    Int J Radiat Oncol Biol Phys; 2019 Nov; 105(4):773-783. PubMed ID: 31408667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective evaluation of hippocampal radiation dose volume effects and memory deficits following cranial irradiation.
    Ma TM; Grimm J; McIntyre R; Anderson-Keightly H; Kleinberg LR; Hales RK; Moore J; Vannorsdall T; Redmond KJ
    Radiother Oncol; 2017 Nov; 125(2):234-240. PubMed ID: 29128167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preservation of memory with conformal avoidance of the hippocampal neural stem-cell compartment during whole-brain radiotherapy for brain metastases (RTOG 0933): a phase II multi-institutional trial.
    Gondi V; Pugh SL; Tome WA; Caine C; Corn B; Kanner A; Rowley H; Kundapur V; DeNittis A; Greenspoon JN; Konski AA; Bauman GS; Shah S; Shi W; Wendland M; Kachnic L; Mehta MP
    J Clin Oncol; 2014 Dec; 32(34):3810-6. PubMed ID: 25349290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hippocampal-sparing and target volume coverage in treating 3 to 10 brain metastases: A comparison of Gamma Knife, single-isocenter VMAT, CyberKnife, and TomoTherapy stereotactic radiosurgery.
    Zhang I; Antone J; Li J; Saha S; Riegel AC; Vijeh L; Lauritano J; Marrero M; Salas S; Schulder M; Zinkin H; Goenka A; Knisely J
    Pract Radiat Oncol; 2017; 7(3):183-189. PubMed ID: 28477798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hippocampal-sparing radiotherapy: the new standard of care for World Health Organization grade II and III gliomas?
    Pinkham MB; Bertrand KC; Olson S; Zarate D; Oram J; Pullar A; Foote MC
    J Clin Neurosci; 2014 Jan; 21(1):86-90. PubMed ID: 24090519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hippocampal-sparing radiotherapy and neurocognitive impairment: A systematic literature review.
    Giuseppe ZR; Silvia C; Eleonora F; Gabriella M; Marica F; Silvia C; Mario B; Francesco D; Savino C; Milly B; Frezza GP; Maurizio Z; Morganti AG
    J Cancer Res Ther; 2020; 16(6):1215-1222. PubMed ID: 33342776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single dose versus fractionated stereotactic radiotherapy for recurrent high-grade gliomas.
    Cho KH; Hall WA; Gerbi BJ; Higgins PD; McGuire WA; Clark HB
    Int J Radiat Oncol Biol Phys; 1999 Dec; 45(5):1133-41. PubMed ID: 10613305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Left hippocampal dosimetry correlates with visual and verbal memory outcomes in survivors of pediatric brain tumors.
    Zureick AH; Evans CL; Niemierko A; Grieco JA; Nichols AJ; Fullerton BC; Hess CB; Goebel CP; Gallotto SL; Weyman EA; Gaudet DE; Nartowicz JA; Ebb DH; Jones RM; MacDonald SM; Tarbell NJ; Yock TI; Pulsifer MB
    Cancer; 2018 May; 124(10):2238-2245. PubMed ID: 29499085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hippocampal dose from stereotactic radiosurgery for 4 to 10 brain metastases: Risk factors, feasibility of dose reduction via re-optimization, and patient outcomes.
    Birer SR; Olson AC; Adamson J; Hood R; Susen M; Kim G; Salama JK; Kirkpatrick JP
    Med Dosim; 2017 Winter; 42(4):310-316. PubMed ID: 28760560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of memory impairment in aging adult survivors of childhood acute lymphoblastic leukemia treated with cranial radiotherapy.
    Armstrong GT; Reddick WE; Petersen RC; Santucci A; Zhang N; Srivastava D; Ogg RJ; Hillenbrand CM; Sabin N; Krasin MJ; Kun L; Pui CH; Hudson MM; Robison LL; Krull KR
    J Natl Cancer Inst; 2013 Jun; 105(12):899-907. PubMed ID: 23584394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating the impact of hippocampal sparing during whole brain radiotherapy on neurocognitive functions: A preliminary report of a prospective phase II study.
    Lin SY; Yang CC; Wu YM; Tseng CK; Wei KC; Chu YC; Hsieh HY; Wu TH; Pai PC; Hsu PW; Chuang CC
    Biomed J; 2015; 38(5):439-49. PubMed ID: 25994802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased cochlear radiation dose predicts delayed hearing loss following both stereotactic radiosurgery and fractionated stereotactic radiotherapy for vestibular schwannoma.
    Patel KS; Ng E; Kaur T; Miao T; Kaprealian T; Lee P; Pouratian N; Selch MT; De Salles AAF; Gopen Q; Tenn S; Yang I
    J Neurooncol; 2019 Nov; 145(2):329-337. PubMed ID: 31552587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.